2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Hyperprolactinemia: new trials by email Literature Review of Hyperprolactinemia trials Research Report on Hyperprolactinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders Aripiprazole, risperidone or paliperidone - Sexual Dysfunction, Hyperprolactinemia | Phase 4 | Unknown | Si Tianmei | 120 | 2013-02-01 | 2013-03-14 |
| Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia Abilify (aripiprazole) - Hyperprolactinemia, Weight Gain | Phase 4 | Unknown | Genovate Biotechnology Co., Ltd., | 2007-10-01 | 2007-10-10 |
Dyslipidemias (1) · Schizophrenia (1) · Sexual Dysfunction, Physiological (1) · Weight Gain (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Endocrine System Diseases (2) · Hyperpituitarism (2) · Hypothalamic Diseases (2) · Nervous System Diseases (2) · Pituitary Diseases (2) · Body Weight (1) · Body Weight Changes (1) · Genital Diseases (1) · Lipid Metabolism Disorders (1) · Mental Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1)
Aripiprazole (2) · Paliperidone Palmitate (1) · Risperidone (1)
Genovate Biotechnology Co., Ltd., (1) · Si Tianmei (1)
China (1)